Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.86 - $6.98 $27 - $104
15 Added 25.0%
75 $0
Q4 2023

Jan 16, 2024

SELL
$1.82 - $3.16 $27 - $47
-15 Reduced 20.0%
60 $0
Q2 2023

Jul 12, 2023

BUY
$7.35 - $13.21 $36 - $66
5 Added 7.14%
75 $0
Q4 2022

Feb 06, 2023

SELL
$11.0 - $21.45 $2.92 Million - $5.69 Million
-265,096 Reduced 99.97%
70 $0
Q3 2022

Oct 18, 2022

BUY
$20.09 - $35.8 $5.32 Million - $9.49 Million
265,054 Added 236655.36%
265,166 $5.57 Million
Q1 2022

Apr 05, 2022

SELL
$36.48 - $52.22 $984 - $1,409
-27 Reduced 19.42%
112 $5,000
Q4 2021

Feb 03, 2022

SELL
$33.11 - $55.01 $167,900 - $278,955
-5,071 Reduced 97.33%
139 $6,000
Q3 2021

Oct 15, 2021

SELL
$50.07 - $66.05 $79,861 - $105,349
-1,595 Reduced 23.44%
5,210 $261,000
Q2 2021

Jul 21, 2021

BUY
$56.61 - $80.46 $40,362 - $57,367
713 Added 11.7%
6,805 $429,000
Q1 2021

Apr 05, 2021

SELL
$86.23 - $125.19 $58,463 - $84,878
-678 Reduced 10.01%
6,092 $566,000
Q4 2020

Jan 20, 2021

SELL
$79.17 - $111.47 $413,663 - $582,430
-5,225 Reduced 43.56%
6,770 $607,000
Q3 2020

Oct 19, 2020

BUY
$81.91 - $134.94 $978,251 - $1.61 Million
11,943 Added 22967.31%
11,995 $1.24 Million
Q2 2020

Jul 29, 2020

BUY
$54.33 - $89.52 $2,825 - $4,655
52 New
52 $4,000
Q1 2019

Apr 10, 2019

SELL
$48.23 - $66.16 $557,876 - $765,272
-11,567 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$55.63 - $73.24 $470,296 - $619,170
8,454 Added 271.57%
11,567 $686,000
Q3 2018

Nov 14, 2018

BUY
$52.05 - $66.51 $162,031 - $207,045
3,113 New
3,113 $205,000
Q2 2018

Aug 14, 2018

SELL
$48.33 - $55.64 $56,932 - $65,543
-1,178 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$44.44 - $54.39 $22,353 - $27,358
503 Added 74.52%
1,178 $62,000
Q4 2017

Feb 14, 2018

BUY
$37.77 - $47.75 $25,494 - $32,231
675
675 $31,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $463M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.